Longitudinal population-based data on effects of kidney dysfunction in the development of stroke and dementia remains inconclusive. We investigated associations of kidney function with risk of stroke and dementia in 5,993 community-dwelling individuals (mean age: 69.0 years, 57.2% women). We calculated estimated glomerular filtration rates based on creatinine, cystatin-C, and a combination of these two. During a mean follow-up of 11.6 years (69,790 person-years), 1,360 individuals suffered a stroke (n = 601) or developed dementia (n = 759). We found that an impaired kidney function was related to a higher risk of stroke, but not to dementia.
HillNR, FatobaST, OkeJL, HirstJA, O’CallaghanCA, LassersonDS, HobbsFD (2016) Global prevalence of chronic kidney disease - a systematic review and meta-analysis. PLoS One11, e0158765.
2.
MannJF, GersteinHC, PogueJ, BoschJ, YusufS (2001) Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial. Ann Intern Med134, 629–636.
3.
GoAS, ChertowGM, FanD, McCullochCE, HsuCY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med351, 1296–1305.
4.
EtgenT, ChoncholM, FörstlH, SanderD (2012) Chronic kidney disease and cognitive impairment: A systematic review and meta-analysis. Am J Nephrol35, 474–482.
5.
ShenZ, RuanQ, YuZ, SunZ (2017) Chronic kidney disease-related physical frailty and cognitive impairment: A systemic review. Geriatr Gerontol Int17, 529–544.
6.
DeckersK, CamerinoI, van BoxtelMPJ, VerheyFRJ, IrvingK, BrayneC, KivipeltoM, StarrJM, YaffeK, de LeeuwPW (2017) Dementia risk in renal dysfunction A systematic review and meta-analysis of prospective studies. Neurology88, 198–208.
7.
BugnicourtJ-M, GodefroyO, ChillonJ-M, ChoukrounG, MassyZA (2013) Cognitive disorders and dementia in CKD: The neglected kidney-brain axis. J Am Soc Nephrol24, 353–363.
8.
MassonP, WebsterAC, HongM, TurnerR, LindleyRI, CraigJC (2015) Chronic kidney disease and the risk of stroke: A systematic review and meta-analysis. Nephrol Dial Transplant30, 1162–1169.
9.
PendleburyST, RothwellPM (2009) Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: A systematic review and meta-analysis. Lancet Neurol8, 1006–1018.
10.
SnowdonDA, GreinerLH, MortimerJA, RileyKP, GreinerPA, MarkesberyWR (1997) Brain infarction and the clinical expression of Alzheimer disease: The Nun Study. JAMA277, 813–817.
11.
IvanCS, SeshadriS, BeiserA, AuR, KaseCS, Kelly-HayesM, WolfPA (2004) Dementia after stroke: The Framingham Study. Stroke35, 1264–1268.
12.
HofmanA, BrusselleGG, MuradSD, van DuijnCM, FrancoOH, GoedegebureA, IkramMA, KlaverCC, NijstenTE, PeetersRP (2015) The Rotterdam Study: 2016 objectives and design update. Eur J Epidemiol30, 661–708.
13.
SedaghatS, HoornEJ, van RooijFJA, HofmanA, FrancoOH, WittemanJCM, DehghanA (2013) Serum uric acid and chronic kidney disease: The role of hypertension. PLoS One8, e76827.
14.
InkerLA, SchmidCH, TighiouartH, EckfeldtJH, FeldmanHI, GreeneT, KusekJW, ManziJ, Van LenteF, ZhangYL (2012) Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med367, 20–29.
15.
DharnidharkaVR, KwonC, StevensG (2002) Serum cystatin C is superior to serum creatinine as a marker of kidney function: A meta-analysis. Am J Kidney Dis40, 221–226.
16.
TruelsenT, BeggS, MathersC (2002) Global burden of cerebrovascular disease in the year 2000. World Health Organization, Geneva.
17.
WieberdinkRG, IkramMA, HofmanA, KoudstaalPJ, BretelerMM (2012) Trends in stroke incidence rates and stroke risk factors in Rotterdam, the Netherlands from 1990 to 2008. Eur J Epidemiol27, 287–295.
18.
BosMJ, KoudstaalPJ, HofmanA, IkramMA (2014) Modifiable etiological factors and the burden of stroke from the Rotterdam study: A population-based cohort study. PLoS Med11, e1001634.
19.
de BruijnRF, BosMJ, PortegiesML, HofmanA, FrancoOH, KoudstaalPJ, IkramMA (2015) The potential for prevention of dementia across two decades: The prospective, population-based Rotterdam Study. BMC Med13, 132.
20.
BosMJ, KoudstaalPJ, HofmanA, BretelerMM (2007) Decreased glomerular filtration rate is a risk factor for hemorrhagic but not for ischemic stroke: The Rotterdam Study. Stroke38, 3127–3132.
21.
de BruijnRFAG, BosMJ, PortegiesMLP, HofmanA, FrancoOH, KoudstaalPJ, IkramMA (2015) The potential for prevention of dementia across two decades: The prospective, population-based Rotterdam Study. BMC Med13, 132.
22.
de BruijnRFAG, SchrijversEMC, de GrootKA, WittemanJCM, HofmanA, FrancoOH, KoudstaalPJ, IkramMA (2013) The association between physical activity and dementia in an elderly population: The Rotterdam Study. Eur J Epidemiol28, 277–283.
23.
BosMJ, KoudstaalPJ, HofmanA, WittemanJCM, BretelerMMB (2006) Uric acid is a risk factor for myocardial infarction and stroke: The Rotterdam study. Stroke37, 1503–1507.
24.
InkerLA, SchmidCH, TighiouartH, EckfeldtJH, FeldmanHI, GreeneT, KusekJW, ManziJ, Van LenteF, ZhangYL, CoreshJ, LeveyAS, InvestigatorsC-E (2012) Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med367, 20–29.
25.
WinklebyMA, JatulisDE, FrankE, FortmannSP (1992) Socioeconomic status and health: How education, income, and occupation contribute to risk factors for cardiovascular disease. Am J Public Health82, 816–820.
26.
MiwaK, TanakaM, OkazakiS, FurukadoS, YagitaY, SakaguchiM, MochizukiH, KitagawaK (2014) Chronic kidney disease is associated with dementia independent of cerebral small-vessel disease. Neurology82, 1051–1057.
27.
O’RourkeMF, SafarME (2005) Relationship between aortic stiffening and microvascular disease in brain and kidney: Cause and logic of therapy. Hypertension46, 200–204.
28.
SafarME, BoudierHS (2005) Vascular development, pulse pressure, and the mechanisms of hypertension. Hypertension46, 205–209.
